Consistent with the above results, we found that CLCA4 was lowly expressed in primary colorectal patients by bioinformatics analysis, and survival analysis of primary colorectal patients found that patients with low expression of CLCA4 had a worse prognosis in survival, suggesting the protective effect of CLCA4 on PCRC patients and its inhibitory effect on cancer. This evidence concerns the gene CLCA4 and cancer.